When you commission a formula from a contract manufacturer, you receive a set of technical documents alongside it. These typically include a formulation specification sheet, a safety data sheet (SDS), a certificate of analysis, and test reports covering stability and preservation. The exact package depends on your product type, your target market, and the regulatory requirements that apply to you. The sections below break down each document so you know exactly what to expect and why it matters.
A contract manufacturer typically provides four core categories of technical documents with a finished formula: a formulation specification sheet, a safety data sheet (SDS), a certificate of analysis (CoA), and test reports such as stability and challenge test results. Together, these documents form the complete technical file you need to manufacture, sell, and defend your product.
Beyond these four, you may also receive additional supporting documents depending on your product and market. These can include INCI ingredient declarations, allergen listings, raw material data sheets, and packaging compatibility reports. For regulated markets such as the EU, this full set of documentation is not optional but a legal requirement before you can place a cosmetic product on the market.
Working with an experienced contract manufacturer means you do not have to chase these documents separately. A well-structured partner provides them as a standard part of the handover, so your product file is complete from day one.
A formulation specification sheet is the master document that defines your product. It records every ingredient by its INCI name and percentage, the manufacturing method, processing parameters such as temperature and mixing sequence, and the finished product’s physical and sensory properties. Think of it as the blueprint that ensures every batch of your product is made identically.
In practical terms, the specification sheet typically contains:
This document is the reference point for quality control. If a batch falls outside specification, the formulation sheet is what the team checks against. It also forms the foundation of your product information file (PIF) for EU compliance.
A safety data sheet (SDS) is a standardised document that describes the hazards of a substance or mixture and provides guidance on safe handling, storage, and emergency measures. For finished cosmetic products intended for consumers, an SDS is not always legally required, but it is typically mandatory when selling to professional or trade customers or when shipping products classified as hazardous.
For natural cosmetic formulas, many finished products do not meet the classification threshold for a hazardous mixture under EU regulations, which means an SDS may not be compulsory for retail sale. However, there are good reasons to have one anyway. Retailers, distributors, and logistics partners often request an SDS as a standard part of their onboarding process. Having one ready removes a common bottleneck when expanding your distribution.
Where an SDS is required, it must follow the 16-section format defined by the EU’s CLP regulation and be provided in the official language of the country where the product is sold. Your contract manufacturer should be able to produce this document or advise you clearly on whether your specific formula requires one.
A certificate of analysis (CoA) is a quality control document that confirms a specific batch of your product meets its defined specifications. It records the results of tests carried out on that batch, including measurements such as pH, viscosity, appearance, and microbial counts, and confirms whether each result passes or fails against the agreed specification.
The CoA is issued per batch, not per formula. This means you will receive a new CoA each time a production run is completed. It serves as proof that what was manufactured matches what was specified, which is important for your own quality records, for regulatory inspections, and for any retailer or distributor that requires batch traceability documentation.
For natural cosmetics in particular, microbial testing results on the CoA are especially significant. Natural formulas without synthetic preservatives require careful preservation strategies, and the CoA provides the documented evidence that each batch is safe from a microbial standpoint at the point of manufacture.
Stability and challenge test reports are the scientific evidence that your product remains safe and effective throughout its intended shelf life. Stability testing confirms that the formula does not separate, change colour, alter in scent, or degrade in efficacy over time under various storage conditions. Challenge testing, also called preservative efficacy testing, confirms that the preservation system in your formula is strong enough to prevent microbial growth if the product is contaminated during normal use.
These reports directly affect your product in several ways:
Stability testing takes time, often several months for full real-time studies, though accelerated testing can provide earlier indications. It is worth factoring this into your launch timeline from the beginning.
To sell a cosmetic product in the EU, you need a complete product information file (PIF) for each product, a product safety report signed by a qualified safety assessor, a notification submitted to the EU’s CPNP portal, and a responsible person established within the EU. The PIF itself must contain your formulation specification, raw material data, stability and challenge test results, manufacturing method, and evidence of compliance with EU Cosmetics Regulation 1223/2009.
The key documents that make up a compliant EU cosmetic product file include:
If you are selling in the UK post-Brexit, the requirements are broadly similar but operate under UK Cosmetics Regulation, with a separate notification through the UK’s SCPN system and a UK-based responsible person. Your contract manufacturer’s documentation should be structured to support both markets if needed.
At Rebel Nature, we understand that navigating cosmetic product documentation can feel overwhelming, especially when you are launching your first product or entering a new market. That is why we make documentation a core part of what we deliver, not an afterthought.
When you work with us, you can expect:
We work exclusively with natural ingredients and maintain a portfolio of over 500 carefully sourced raw materials, which means our formulas are built with traceability and transparency in mind from the very first step. You can learn more about how we work and the process we follow with every client.
If you are ready to get started or have questions about the documentation that comes with your formula, we are happy to walk you through it. Get in touch with us and let us help you bring your natural cosmetic product to market with confidence.
The timeline varies depending on the document type. A formulation specification sheet and safety data sheet can usually be provided shortly after formula development is complete. Certificates of analysis are issued after each production run. Stability and challenge test reports take the longest — accelerated stability testing typically takes 8–12 weeks, while full real-time studies can take 12–24 months. Factor these timelines into your product launch plan from the very beginning to avoid delays.
Any change to your formula — even a minor ingredient substitution or a percentage adjustment — requires the technical documents to be updated. This typically means a revised formulation specification sheet, a new or amended SDS, and potentially repeat stability and challenge testing if the change could affect product safety or shelf life. Always discuss proposed changes with your contract manufacturer before making them, as some modifications may reset your compliance timeline significantly.
Much of the underlying technical data — such as your formulation specification, stability results, and challenge test reports — applies to both markets. However, the regulatory frameworks are separate post-Brexit, meaning you will need a CPNP notification for the EU and a separate SCPN notification for the UK, along with a responsible person established in each territory. Your SDS and labelling may also need market-specific versions. A good contract manufacturer will flag these differences and help you structure your documentation to cover both markets efficiently.
A responsible person (RP) is a legal entity — an individual or a company — established within the EU (or UK) who takes legal responsibility for a cosmetic product’s compliance before it is placed on the market. Yes, you must have one in place before you can legally sell. If you are based outside the EU or UK, you will need to appoint a third-party responsible person in each relevant territory. Some contract manufacturers can assist with RP introductions, or you can work with a dedicated regulatory consultancy to fulfil this requirement.
Accelerated stability testing exposes your product to elevated temperature and humidity conditions (typically 40°C and 75% relative humidity) over a shorter period — usually 8–12 weeks — to simulate ageing and provide an early indication of shelf life. Real-time stability testing stores the product under normal conditions over the full intended shelf life period. For EU compliance, real-time data is ultimately required to substantiate shelf life claims, but accelerated results are widely accepted as interim evidence while real-time studies are ongoing. Most brands use both in parallel to keep their launch timeline on track.
The most common mistake is treating documentation as a final step rather than an integrated part of product development. Waiting until a formula is finalised before starting stability testing, for example, can delay a launch by several months. Other frequent issues include missing or incomplete raw material data sheets from suppliers, INCI declarations that do not match the actual formula, and SDS documents that are not translated into the required language for each target market. Working with a contract manufacturer who builds documentation into the development process from the start helps you avoid all of these pitfalls.
Ownership of formulation documents depends on the terms agreed with your contract manufacturer. If you commissioned and paid for the formula development, you should own the intellectual property, including the formulation specification sheet — but this must be clearly stated in your contract. Always clarify IP ownership before signing any agreement. If you do own the documents, you can in principle take your specification sheet to another manufacturer, though the new manufacturer may need to validate the formula in their own facility and re-run relevant tests to issue their own certificates of analysis.
Follow us on social media to stay up to date with the latest at Rebel-Nature.
REBEL-NATURE BV COPYRIGHT 2026 ©